Early breast cancer - the randomised evidence

Early breast cancer - the randomised evidence

Bibliographic Details
Main Authors:	Peto, R, Clarke, R, Collins, R, Davies, C, Godwin, J, Gray, R
Format:	Journal article
Published:	1999

Similar Items

Facts and figures from the meta-analyses in breast cancer
by: Peto, R, et al.
Published: (1998)

Radiotherapy and surgery in early breast cancer - Reply
by: Peto, R, et al.
Published: (1996)

The EBCTCG overview of adjuvant therapy of breast cancer. What are the implications for future studies? Early Breast Cancer Trialists' Collaborative Group.
by: Gray, R, et al.
Published: (1993)

Early breast cancer: How long should tamoxifen continue?
by: Davies, C, et al.
Published: (1999)

EARLY BREAST-CANCER TRIALISTS COLLABORATION
by: Peto, R
Published: (1987)

Early breast cancer: How long should tamoxifen continue?
by: Davies, C, et al.
Published: (1998)

Tamoxifen for early breast cancer: better late than never.
by: Gray, R, et al.
Published: (2000)

Anthracycline and taxane containing chemotherapy for early-stage operable breast cancer: meta-analyses of 100,000 women in 86 randomised trials
by: Braybrooke, J, et al.
Published: (2023)

Tamoxifen therapy for patients with breast cancer - Authors' reply.
by: Davies, C, et al.
Published: (2013)

Overview of the Randomised Trials of Radiotherapy in Early Breast Cancer.
by: Darby, S, et al.
Published: (2009)

Polychemotherapy for early breast cancer: an overview of the randomised trials
by: Early Breast Cancer Trialists' Collaborative Group
Published: (1998)

Tamoxifen for early breast cancer: an overview of the randomised trials
by: Early Breast Cancer Trialists' Collaborative Group
Published: (1998)

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials
by: Gray, R, et al.
Published: (2019)

Update of the worldwide evidence on the adjuvant treatment of breast cancer
by: Peto, R, et al.
Published: (2002)

Ovarian ablation in early breast cancer: overview of the randomised trials
by: Early Breast Cancer Trialists' Collaborative Group
Published: (1996)

WITHDRAWN: Radiotherapy for early breast cancer.
by: Clarke, M
Published: (2008)

WITHDRAWN: Tamoxifen for early breast cancer.
by: Clarke, M
Published: (2008)

Making randomised trials larger: a simple solution?
by: Gray, R, et al.
Published: (1995)

Management of breast cancer.
by: Peto, R
Published: (1992)

Estimating the risks of breast cancer radiotherapy: Evidence from modern radiation doses to the lungs and heart and from previous randomised trials
by: Taylor, C, et al.
Published: (2017)

THE EBCTCG OVERVIEW OF ADJUVANT THERAPY OF BREAST-CANCER
by: Gray, R, et al.
Published: (1994)

Effects of radiotherapy and surgery for early breast cancer - Authors' reply
by: Darby, S, et al.
Published: (2006)

Meta-analyses of adjuvant therapies for women with early breast cancer: the Early Breast Cancer Trialists' Collaborative Group overview.
by: Clarke, M
Published: (2006)

WITHDRAWN: Ovarian ablation for early breast cancer.
by: Clarke, M
Published: (2008)

RAUWOLFIA DERIVATIVES AND BREAST-CANCER
by: Peto, R
Published: (1974)

Aromatase Inhibitors (AIs) Versus Not (Placebo/Observation) as Late Extended Adjuvant Therapy for Postmenopausal Women with Early Stage Breast Cancer (BC): Overviews of Randomized Trials of AIs after similar to 5 Years of Tamoxifen
by: Goss, P, et al.
Published: (2009)

A randomised controlled trial of an intervention to promote early presentation of breast cancer in older women: effect on breast cancer awareness.
by: Linsell, L, et al.
Published: (2009)

WITHDRAWN: Multi-agent chemotherapy for early breast cancer.
by: Clarke, M
Published: (2008)

CYTO-TOXIC CHEMOTHERAPY IN BREAST-CANCER
by: Peto, R
Published: (1985)

Birthweight as risk factor for breast cancer.
by: Peto, R
Published: (1997)

Long-term mortality from heart disease after radiotherapy for early breast cancer
by: Darby, S, et al.
Published: (2007)

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
by: Davies, C, et al.
Published: (2013)

CYTO-TOXIC CHEMOTHERAPY IN BREAST-CANCER - REPLY
by: Peto, R
Published: (1985)

The 2006 worldwide overview of the effects of local treatments for early breast cancer on long-term outcome
by: McGale, P, et al.
Published: (2006)

The 2006 worldwide overview of the effects of local treatments for early breast cancer on long-term outcome
by: Darby, S, et al.
Published: (2006)

Cognitive function in women with early breast cancer receiving adjuvant chemotherapy
by: Lacey, RT, et al.
Published: (2006)

UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.
by: Peto, R, et al.
Published: (2000)

Breast cancer and breastfeeding - Reply
by: Beral, V, et al.
Published: (2003)

Routine follow up of breast cancer in primary care: randomised trial.
by: Grunfeld, E, et al.
Published: (1996)

ONLY ONE BREAST REMAINS AT RISK OF CONTRALATERAL CANCER
by: Peto, R
Published: (1987)